[On the pharmacology of quaternary derivatives of beta-phenylethylamine].
D000818:Animals; D001001:Anura; D001794:Blood Pressure / Q000187:drug effects; D001949:Bretylium Compounds / Q000494:pharmacology; D001966:Bromine; D002415:Cats; D002800:Cholinesterase Inhibitors / Q000494:pharmacology; D005725:Ganglia, Autonomic / Q000187:drug effects; D005730:Ganglionic Blockers / Q000494:pharmacology; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology; D009130:Muscle, Smooth / Q000187:drug effects; D009469:Neuromuscular Junction / Q000187:drug effects; D009541:Nictitating Membrane / Q000187:drug effects; D010627:Phenethylamines / Q000494:pharmacology*; D000644:Quaternary Ammonium Compounds / Q000494:pharmacology; D011817:Rabbits; D011955:Receptors, Drug; D013566:Sympathomimetics / Q000494:pharmacology*; D014439:Tyramine / Q000494:pharmacology
D001949:Bretylium Compounds; D002800:Cholinesterase Inhibitors; D005730:Ganglionic Blockers; D008996:Monoamine Oxidase Inhibitors; D010627:Phenethylamines; D000644:Quaternary Ammonium Compounds; D011955:Receptors, Drug; D013566:Sympathomimetics; D001966:Bromine; D014439:Tyramine
Zur Pharmakologie quartärer Derivate des beta-Phenyläthylamins.